Potential of Inflammatory Biomarkers to Guide Treatment in Mild Asthma
June 27, 2024
June 27, 2024
DENVER, Colorado, June 27 (TNSres) -- National Jewish Health, a respiratory hospital, issued the following news release on June 26, 2024:
National Jewish Health researchers are looking for ways to identify patients with untreated mild persistent asthma who might benefit from daily inhaled treatment based on inflammatory biomarkers. Their results were published in April in the Journal of Allergy and Clinical Immunology (JACI) In Practice.
"Patients with severe asthm . . .
National Jewish Health researchers are looking for ways to identify patients with untreated mild persistent asthma who might benefit from daily inhaled treatment based on inflammatory biomarkers. Their results were published in April in the Journal of Allergy and Clinical Immunology (JACI) In Practice.
"Patients with severe asthm . . .